POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season

por Ngami, A, Guelfucci, F, Bianic, F, Net, P
Publicado 2022

EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon?

por Ngami, A, Christie, T, Guelfucci, F, Bianic, F, Net, P
Publicado 2022

RWD111 Influenza Vaccine Sales During the COVID-19 Era

por Ngami, A, Christie, T, Guelfucci, F, Bianic, F, Net, P
Publicado 2022

PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population

por Net, P., Costa, M., Proshenska, D., Bianic, F., Guelfucci, F.
Publicado 2020

PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population

por Costa, M., Net, P., Proshenska, D., Bianic, F., Guelfucci, F.
Publicado 2020

POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States

por Ngami, A, Christie, T, Ménin, G, Guelfucci, F, Bianic, F, Net, P
Publicado 2022

POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital

por Cazin, L, Ngami, A, Parrenne, L, le Mercier, F, Guelfucci, F, Bianic, F, Lecoeur, A, Net, P
Publicado 2022